Back to results
CompletedPhase 3

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

NCT02489968

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Tokai Memorial Hospital

Aichi, Kasugai, Japan

+82 additional locations

View on ClinicalTrials.gov